Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

merz pharmaceuticals gmbh - l-ornitina l-aspartato - l-ornitina l-aspartato....3g

Malta - English - Medicines Authority

merz pharmaceuticals gmbh eckenheimer landstrasse 100, d-60318 frankfurt am main, germany - l, ornithine, aspartate - granules for oral solution - l-ornithine 3 g/5g l-aspartate 3 g/5g - bile and liver therapy

Malta - English - Medicines Authority

merz pharmaceuticals gmbh eckenheimer landstrasse 100, d-60318 frankfurt am main, germany - l, ornithine, aspartate - concentrate for solution for infusion - l-ornithine 5 g/ml l-aspartate 5 g/ml - bile and liver therapy

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

latin farma, s.a. - l-citrulina - l-citrulina....1.25 mg / l-ornitina clorhidrato....1.25 mg / l-arginina clorhidrato....5.00 mg / cianocobalamina....25.00 mcg / extracto hepÁtico....30.00 mg

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - eflornithine hydrochloride (unii: 4nh22ndw9h) (eflornithine - unii:zqn1g5v6sr) - eflornithine hydrochloride anhydrous 139 mg in 1 g - vaniqa (eflornithine hydrochloride) cream, 13.9% is indicated for the reduction of unwanted facial hair in women. vaniqa has only been studied on the face and adjacent involved areas under the chin of affected individuals. usage should be limited to these areas of involvement. vaniqa is contraindicated in patients with a history of sensitivity to any components of the preparation.

United States - English - NLM (National Library of Medicine)

allergan, inc. - eflornithine hydrochloride (unii: 4nh22ndw9h) (eflornithine - unii:zqn1g5v6sr) - eflornithine hydrochloride anhydrous 139 mg in 1 g - vaniqa ®   (eflornithine hydrochloride) cream, 13.9% is indicated for the reduction of unwanted facial hair in women. vaniqa ® has only been studied on the face and adjacent involved areas under the chin of affected individuals. usage should be limited to these areas of involvement. vaniqa ® is contraindicated in patients with a history of sensitivity to any components of the preparation.

Israel - English - Ministry of Health

medison pharma ltd - eflornithine as hydrochloride monohydrate - cream - eflornithine as hydrochloride monohydrate 11.5 %w/w - eflornithine - eflornithine - vaniqa is indicated for the reduction of unwanted facial hair in women.

Australia - English - Department of Health (Therapeutic Goods Administration)

a menarini australia pty ltd - eflornithine hydrochloride -

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

cjsc canonpharma production - ornithine (ornithine aspartate) - granules for oral solution - 3000mg